Sunshine Biopharma Inc banner

Sunshine Biopharma Inc
NASDAQ:SBFM

Watchlist Manager
Sunshine Biopharma Inc Logo
Sunshine Biopharma Inc
NASDAQ:SBFM
Watchlist
Price: 0.998 USD -4.04%
Market Cap: $4.9m

Wall Street
Price Targets

SBFM Price Targets Summary
Sunshine Biopharma Inc

Wall Street analysts forecast SBFM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SBFM is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
507% Upside
Average
Price Target
6.12 USD
513% Upside
Highest
Price Target
6.3 USD
531% Upside
Sunshine Biopharma Inc Competitors:
Price Targets
WLFC
Willis Lease Finance Corp
-5% Downside

Revenue
Forecast

N/A
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

The compound annual growth rate of Sunshine Biopharma Inc's revenue for the next 1 year is 40%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-75%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-75%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SBFM's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for SBFM is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

What is Sunshine Biopharma Inc's Revenue forecast?
Projected CAGR
40%

The compound annual growth rate of Sunshine Biopharma Inc's revenue for the next 1 year is 40%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett